Complete the medication-safety plan for a hemodialysis client starting etelcalcetide.
Drop-down Cloze
Choose your responses, then check the answer.
Explanation
Cinacalcet is discontinued for at least 7 days, etelcalcetide is administered after blood is no longer circulating through the dialyzer, calcium is checked within 1 week of initiation or dose adjustment, and symptomatic or severe hypocalcemia requires stopping and treatment.
Quick answer Link the switch interval, post-dialysis route, and calcium safety threshold.
Why this is correct Etelcalcetide is removed by the dialyzer and lowers serum calcium. Overlapping calcium-sensing receptor agonists or giving the dose before dialysis completion increases preventable risk.
Easy analogy or mental picture Build a medication safety chain: identify the cue cluster, connect it to the drug mechanism, stop preventable exposure, stabilize the client, and verify the response with measurable findings.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving treatment for the underlying condition.
Why the other choices are wrong Options that rely on one reassuring value, continue a suspect exposure, bypass monitoring, or delay escalation leave the medication hazard active.